Diligence memo · auto-generated · as of July 2, 2026
Pharmaceutical Resource Technology, Inc.
Pharmaceutical Resource Technology, Inc. looks over-valued against its niche peers and is active on financing cadence.
Businessfiled
Pharmaceutical Resource Technology, Inc. operates in Pharmaceuticals, based in Singapore.
Sub-sector tags: pharma.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Pharmaceutical Resource Technology, Inc. has raised $10M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $10M on 2025-03-17.
Most recent recorded round closed around 2025-03-17.
Valuation (modeled)modeled
Provath models Pharmaceutical Resource Technology, Inc. at approximately $37M (range $11M–$69M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 2.32× the median modeled value of Series A Pharmaceuticals companies in 2025–2027 (37 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Last raise 16 mo ago; this sector typically re-raises about every 13 months.
Raising on or ahead of the sector's normal rhythm.
Comparablesmixed
Capital scale ranks ahead of 54% of Pharmaceuticals peers (1613 compared).
Modeled value ranks above 37% of those peers.
Closest niche peers: Incannex Healthcare Inc., Retension Pharmaceuticals, Inc., Eikonoklastes Therapeutics, Inc., Phoenicis Therapeutics, Inc., Cristcot LLC.
Peoplefiled
2 named people on file across officers, directors and signatories.
Risks & flagsmixed
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.